financetom
Business
financetom
/
Business
/
GrowGeneration Q2 sales narrowly miss estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
GrowGeneration Q2 sales narrowly miss estimates
Aug 11, 2025 1:52 PM

Overview

* GrowGeneration Corp ( GRWG ) Q2 net sales rise 14.7% sequentially, missing analyst expectations

* Proprietary brand sales grow to 32% of cultivation and gardening revenue

* Store operating expenses down 22.9% yr/yr, reflecting cost control measures

Outlook

* The owner of specialty retail hydroponic and organic gardening stores expects Q3 2025 net sales to exceed $41 mln

* GrowGeneration ( GRWG ) not providing full-year 2025 guidance due to macroeconomic uncertainty

* Company exploring strategies to mitigate risks from global trade policies

* GrowGeneration ( GRWG ) adjusting pricing strategies amid retail pricing pressure

Result Drivers

* PROPRIETARY BRAND SALES - Proprietary brand sales increased to 32% of cultivation and gardening revenue, driven by strategic initiatives

* COST CONTROL - Store operating expenses declined 22.9% yr/yr, reflecting effective cost control measures

* RETAIL CONSOLIDATION - Net loss impacted by decreased sales volume due to fewer retail locations

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Sales Miss $40.96 $41 mln

mln (3

Analysts

)

Q2 EPS -$0.08

Q2 Net -$4.81

Income mln

Q2 Basic -$0.08

EPS

Q2 Gross $11.59

Profit mln

Q2 -$4.81

Pretax mln

Profit

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the home improvement products & services retailers peer group is "buy."

* Wall Street's median 12-month price target for GrowGeneration Corp ( GRWG ) is $1.88, about 44% above its August 8 closing price of $1.05

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UniCredit secures ECB's approval for Commerzbank stake
UniCredit secures ECB's approval for Commerzbank stake
Mar 14, 2025
MILAN (Reuters) -The European Central Bank has given UniCredit approval to buy up to 29.9% of Commerzbank, the Italian bank said on Friday, potentially paving the way for CEO Andrea Orcel to pursue a takeover of Germany's second-biggest listed bank. ECB approval was expected given UniCredit's financial strength and a supervisory stance which is supportive of consolidation efforts, but it...
DigitalBridge Unit Enters Deal to Acquire Crown Castle's Fiber Solutions Business in $4.25 Billion Deal
DigitalBridge Unit Enters Deal to Acquire Crown Castle's Fiber Solutions Business in $4.25 Billion Deal
Mar 14, 2025
03:36 AM EDT, 03/14/2025 (MT Newswires) -- DigitalBridge Group ( DBRG/PJ ) said late Thursday its portfolio company Zayo has agreed to acquire Crown Castle's fiber solutions business in a deal worth $4.25 billion. The deal adds about 90,000 route miles of fiber to Zayo's network, the company said. Closing of the deal is expected to occur in H1 2026,...
BrightView Launches $100 Million Share Buyback Program
BrightView Launches $100 Million Share Buyback Program
Mar 14, 2025
03:29 AM EDT, 03/14/2025 (MT Newswires) -- BrightView Holdings ( BV ) said late Thursday its board has approved the repurchase of up to $100 million shares of the company's common stock. The program has no time limit, the company said. ...
Krystal Biotech Insider Sold Shares Worth $8,889,525, According to a Recent SEC Filing
Krystal Biotech Insider Sold Shares Worth $8,889,525, According to a Recent SEC Filing
Mar 14, 2025
03:25 AM EDT, 03/14/2025 (MT Newswires) -- Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on March 13, 2025, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,889,525. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,136,767 common shares of the company, with 1,533,056 shares held directly and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved